Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Racial differences in hormone replacement therapy prescriptions.

J V Marsh1, K M Brett, L C Miller

  • 1Division of Epidemiology, National Center for Health Statistics/Centers for Disease Control and Prevention, Hyattsville, Maryland, USA. jmarsh@jhsph.edu

Obstetrics and Gynecology
|June 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Animal board invited review: Benefits of livestock and animal-source foods in developing countries.

Animal : an international journal of animal bioscience·2026
Same author

Better Social-emotional Behavior in Young Nepali Children is Associated with Household Wealth, Child Age, and Family Participation in a Community Development Intervention.

Kathmandu University medical journal (KUMJ)·2024
Same author

Management of Xiphinema americanum and Soybean Severe Stunt in Soybean Using Crop Rotation.

Plant disease·2019
Same author

Markers of inflammation in the prefrontal cortex of individuals with schizophrenia.

Molecular psychiatry·2013
Same author

Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.

Molecular psychiatry·2012
Same author

Pharmacology.

Annual review of physiology·2010
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

Black and white women aged 45-64 have similar rates of ambulatory care visits, but white women are twice as likely to receive hormone replacement therapy (HRT) prescriptions.

Area of Science:

  • Reproductive Health
  • Health Disparities
  • Clinical Pharmacy

Background:

  • Hormone replacement therapy (HRT) is a common treatment for menopausal symptoms.
  • Understanding racial disparities in HRT utilization is crucial for equitable healthcare.
  • Previous studies have suggested differences in HRT use between racial groups.

Purpose of the Study:

  • To investigate racial disparities in hormone replacement therapy (HRT) prescription rates.
  • To analyze the relative risks and rates of HRT prescriptions for Black and White women.
  • To identify factors influencing these racial differences in HRT use.

Main Methods:

  • Analysis of data from the National Ambulatory Medical Care Surveys (1993-1995).
  • Inclusion of 25,203 visits by Black and White women aged 45-64.

Related Experiment Videos

  • Logistic regression used to control for confounders and estimate the effect of race on HRT prescription.

    • Main Results:

    • White women had a 9.7% HRT prescription rate, while Black women had a 4.5% rate.
    • Racial disparity in HRT prescriptions persisted after controlling for physician and visit characteristics (OR 2.1).
    • Ambulatory care visit rates were similar, but HRT prescription rates were double for white women.

    Conclusions:

    • Significant racial differences in hormone replacement therapy (HRT) use exist between Black and White women.
    • These disparities persist even after accounting for physician and visit-related factors.
    • Further research is needed to understand the underlying causes of these inequities in HRT access and utilization.